Biological similarities between murine chemical-induced and natural human bladder carcinogenesis

Oncology Letters

Volumn 1, Issue 2, 2010, Pages 373-377

  Palmeira, Carlos ^a,b   Oliveira, Paula A ^d   Lameiras, Catarina ^a   Amaro, Teresina ^a   Silva, Victor M ^a   Lopes, Carlos ^c   Santos, Lúcio ^a,b  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

Bladder carcinogenesis model; DNA content; Human; Ki 67; P53; Rat

Indexed keywords

DNA; KI 67 ANTIGEN; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; PROTEIN P53;

ANEUPLOIDY; ANIMAL CELL; ANIMAL DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; BLADDER CANCER; BLADDER CARCINOGENESIS; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE CARCINOMA; NONHUMAN; PAPILLARY CARCINOMA; PROTEIN EXPRESSION; RAT; UROTHELIUM;

EID: 77955737369     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol_00000066     Document Type: Article

References (21)

1. Höglund M: Bladder cancer, a two phased disease? Semin Cancer Biol 17: 225-232, 2007.
2. Crallan RA, Georgopoulos NTand Southgate J: Experimental models of human bladder carcinogenesis. Carcinogenesis 27: 374-381, 2006.
3. Oliveira PA, Colaço A, De la Cruz PLF and Lopes C: Experimental bladder carcinogenesis-rodent models. Exp Oncol 28: 2-11, 2006.
4. Arentsen HC, Hendricksen K, Oosterwijk Eand Witjes JÁ: Experimental rat bladder urothelial cell carcinoma models. World J Urol 27: 313-317, 2009.
5. Grubbs CJ, Lubet RA, Koki AT, Leahy KM, Masferrer JL, Steele VE, Kelloff GF, Hill DLand Seibert K: Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res 60: 5599-5602, 2000.
6. Oliveira PA, Palmeira C, Lourenço LMand Lopes CA: Evaluation of DNA content in preneoplastic changes of mouse urinary bladder induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. J Exp Clin Cancer Res 24: 609-616, 2005.
7. Williams PD, Lee JK and Theodorescu D: Molecular credentialing of rodent bladder carcinogenesis models. Neoplasia 10: 838-846, 2008.
8. Druckrey H, Preussmann R, Ivankovic S, Schmidt CH, Mennel HD and Stahl KW: Selective induction of bladder cancer in rats by dibutyl-and N-butyl-n-(4-hydroxybutyl)nitrosamine. Z Krebsforsch 66: 280-290, 1964.
9. Kunze E, Schauer A and Schatt S: Stages of transformation in the development of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced transitional cell carcinomas in the urinary bladder of rats. Z Krebsforch Klin Onkol Cancer Res Clin Oncol 87: 139-160, 1976.
10. Oliveira PA, Palmeira C, Colaço A, De La Cruz PLF and Lopes C: DNA content analysis, expression of Ki-67 and p53 in rat urothelial lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and treated with mitomycin Cand bacillus Calmette-Guérin. Anticancer Res 26: 2995-3004, 2006.
11. Palmeira C, Oliveira PA, Arantes-Rodrigues R, Colaço A, De la Cruz PLF, Lopes Cand Santos L: DNA cytometry and kinetics of rat urothelial lesions during chemical carcinogenesis. Oncol Rep 21: 247-252, 2009.
12. Palmeira C, Lameiras C, Amaro T, Lima L, Kock A, Lopes C, Oliveira PA and Santos L: CISis a surrogate marker of genetic instability and field carcinogenesis in the urothelial mucosa. Urol Oncol, Oct. 23, 2009 (Epub ahead of print).
13. Greene FL, Page DL, Fleming ID, et al: AJCCCancer Staging Manual. 6th edition. Springer Verlag, New York, 2002.
14. Sauter G, Algaba F, Amin M, et al: Tumours of the urinary system: non-invasive urothelial neoplasias. In: WHO Classification of Tumours of the Urinary System and Male Genital Organs. Eble JN, Sauter G, Epstein JLand Sesterhenn I (eds). IARCCPress, Lyon, pp110-123, 2004.
15. Lopez-Beltran A, Sauter G, Gasser T, et al: Tumours of the urinary system: infiltrating urothelial carcinoma. In: WHO Classification of Tumours of the Urinary System and Male Genital Organs. Eble JN, Sauter G, Epstein JLand Sesterhenn I (eds). IARCCPress, Lyon, pp93-109, 2004.
16. Santos L, Amaro T, Costa C, Pereira S, Bento MJ, Lopes P, Oliveira J, Criado B and Lopes C: Ki-67 index enhances the prognostic accuracy of the urothelial supeficial bladder carcinoma risk group classification. Int J Cancer 105: 267-272, 2003.
17. Palmeira CA, Oliveira PA, Seixas F, Pires MA, Lopes Cand Santos L: DNA image cytometry in bladder cancer: state of the art. Anticancer Res 28: 443-450, 2008.
18. Cordon-Cardo C: Molecular alterations associated with bladder cancer initiation and progression. Scand J Urol Nephrol 42: S154-S165, 2008.
19. Lacy S, Lopez-Beltran A, MacLennan GT, Foster SR, Montironi Rand Cheng L: Molecular pathogenesis of urothelial carcinoma - the clinical utility of emerging new biomarkers and future molecular classification of bladder cancer. Anal Quant Cytol Histol 31: 5-16, 2009.
20. Margulis V, Lotan Y, Karakiewicz PI, et al: Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer. J Natl Cancer Inst 101: 114-119, 2009.
21. Spiess PEand Czerniak B: Dual-track pathway of bladder carcinogenesis. Practical implications. Arch Pathol Lab Med 130: 844-852, 2006.